90-day money back guarantee
Spread the cost, interest-free

Not Just Claimed.

Clinically proven to relieve leg aches & pains

Revitive uses Neuromuscular Electrical Stimulation (NMES), delivered through patented OxyWave patterns, to activate your leg muscles and increase blood flow with meaningful benefits shown in controlled clinical trials.

Not Just Claimed.

Clinically proven to relieve leg aches & pains

Revitive uses Neuromuscular Electrical Stimulation (NMES), delivered through patented OxyWave patterns, to activate your leg muscles and increase blood flow with meaningful benefits shown in controlled clinical trials.

4m+ users worldwide

4m+ users worldwide

5-star reviews

5000+ 5 Star Reviews

Medical devices

14+ years of research

Clinically proven

9 published clinical papers

Clinically studied with

Leading Universities

Revitive’s key clinical claims are supported by peer-reviewed and controlled clinical research conducted with respected universities, clinicians and healthcare researchers

Clinical LP - Logos

Clinical Evidence

The results speak for themselves

2x

greater reduction in leg pain¹

65%

further distance walked before pain started²

5x

more likely to feel noticeable improvements in daily activities¹

3x

increase in blood flow¹

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

Revitive vs sham

Participants who used Revitive experienced twice the reduction in leg pain compared to the sham control group. Improvements exceeded the Minimal Clinically Important Difference (MCID) and reached statistical significance (p<0.05) at week 8. These benefits were sustained at 12 weeks among participants using the Vigorous program, 4 weeks after stopping treatment..

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

PARTICIPANTS

42 adults

DURATION

6 weeks

MEASURE

Initial claudication distance

Participants with Peripheral Arterial Disease who used Revitive alongside a supervised exercise programme walked 65% further before pain started compared to where they began — an average increase of 40 metres in pain-free walking distance after just 6 weeks of daily use.

Randomised Controlled Trial conducted in patients with mild Peripheral Arterial Disease experiencing intermittent claudication. Results measured at 6 weeks vs baseline. Results may vary.

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

COPM score

Participants who used Revitive daily were 5 times more likely to report real-life improvements in everyday activities, including walking, sleeping, climbing stairs, and standing, compared to the sham control group. Benefits were still reported 4 weeks after stopping treatment.

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

Blood flow

Blood flow volume and velocity in the legs increased approximately 3 times during Revitive use compared to the sham control group, a significant improvement in circulation measured throughout the 8-week trial.

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

2x

greater reduction in leg pain¹

65%

further distance walked before pain started²

5x

more likely to feel noticeable improvements in daily activities¹

3x

increase in blood flow¹

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

Leg pain vs sham

Participants who used Revitive experienced twice the reduction in leg pain compared to the sham control group. Improvements exceeded the Minimal Clinically Important Difference (MCID) and reached statistical significance (p<0.05) at week 8. These benefits were sustained at 12 weeks among participants using the Vigorous program, 4 weeks after stopping treatment.

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

PARTICIPANTS

42 adults

DURATION

6 weeks

MEASURE

Initial claudication distance

Participants with Peripheral Arterial Disease who used Revitive alongside a supervised exercise programme walked 65% further before pain started compared to where they began — an average increase of 40 metres in pain-free walking distance after just 6 weeks of daily use.

RCT conducted in patients with mild Peripheral Arterial Disease experiencing intermittent claudication. Results measured at 6 weeks vs baseline. Results may vary.

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

COPM score vs sham

Participants who used Revitive daily were 5 times more likely to report real-life improvements in everyday activities, including walking, sleeping, climbing stairs, and standing, compared to the sham control group. Benefits were still reported 4 weeks after stopping treatment.

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

PARTICIPANTS

127 adults

DURATION

8 weeks

MEASURE

Blood flow vs sham

Blood flow volume and velocity in the legs increased approximately 3 times during Revitive use compared to the sham control group, a significant improvement in circulation measured throughout the 8-week trial.

Sham-controlled Randomised Controlled Trial. Conducted on community-dwelling adults aged 65+ with self-reported leg symptoms, not necessarily diagnosed conditions. Results may vary.

Read the Clinical Studies

This isn't just a gadget

It's a certified medical device

Revitive is developed under strict medical-device quality and regulatory standards. That means its design, manufacturing and safety processes are independently audited and controlled.

Registered medical device

Revitive is a Class IIa registered medical device.

Registered with the UK MHRA

The official regulatory body responsible for ensuring that medicines and medical devices used in the UK are safe, effective, and of high quality.

NHS approved clinical trials

Every UK trial was registered with and approved by the NHS Health Research Authority.

Proven safety record

Across all 9 published trials. Not one participant reported a harmful side effect.

This isn't just a gadget

It's a certified medical device

Revitive is developed under strict medical-device quality and regulatory standards. That means its design, manufacturing and safety processes are independently audited and controlled.

Registered medical device

Revitive is a Class IIa registered medical device.

Registered with the UK MHRA

The official regulatory body responsible for ensuring that medicines and medical devices used in the UK are safe, effective, and of high quality.

NHS approved clinical trials

Every UK trial was registered with and approved by the NHS Health Research Authority.

Proven safety record

Across all 9 published trials. Not one participant reported a harmful side effect.

Clinical LP - Graph 2

What makes

Revitive different?

It's not about higher intensity - it's about delivering a better therapy. By combining patented OxyWave®and IsoRocker® technologies, Revitive goes beyond conventional foot stimulation to activate the leg muscles, support increased blood flow during use, and help you move with greater comfort.

Meet the team

The clinical & scientific experts behind Revitive

Don’t take our word for it

Hear from the people who’ve tried it

No longer need strong painkillers… walking better, hardly limping

“I have used it everyday for the past two weeks and what a difference it has made to my life.”

Ali R

I’ve had problems with my legs and feet for years. I feel fantastic I’ve recommended it to my co-workers as well

“Professional from start to finish. Five stars.”

Maureen S

I feel free now to do what I want… walking faster, up and down stairs again.

“I'm a lollipop lady and clean a school so I walk miles. Also have a dog. This is a life saver.”

Rosemary S

After trying the cheaper copies, took the plunge and noticed the benefit after a week.

“We contemplated for a while about spending this amount of money but I can highly recommend the Revitive Medic.”

Judith D

This product has changed my life

“I can walk so much better and next to no pain in bed at night. Thank you .”

Claire P

Don’t take our word for it

Hear from the people who’ve tried it

Feel it working

From the first use

With Revitive, you’re not just sitting, you can feel the neuromuscular stimulation working your leg muscles, helping them contract and relax to improve blood flow.

Try it at home, risk-free

Every Revitive comes with a 90-day money-back guarantee. If it’s not right for you, return it for a full refund.

Try it now

1: Kumaran B, Targett D, Watson T. Benefits of home-based foot neuromuscular electrical stimulation on self-reported function, leg pain and other leg symptoms among community-dwelling older adults: a sham-controlled randomised clinical trial. BMC Geriatr. 2024; 24:683.

2: Babber A, Ravikumar R, Onida S, Lane TRA, Davies AH. Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial. Br J Surg. 2020;107(4):355-363.

Take the quiz to save an extra £10

Discover your ideal Circulation Booster - then try it risk-free for 90-days.